GLP-1 receptor agonists for Parkinson's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GLP-1 receptor agonists for Parkinson's disease

Published:2020-07-23 Issue:7 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Mulvaney Caroline A¹,Duarte Gonçalo S²³,Handley Joel¹⁴,Evans David JW¹,Menon Suresh⁵,Wyse Richard⁶,Emsley Hedley CA¹⁷

Affiliation:

1. Lancaster Medical School; Lancaster University; Lancaster UK

2. Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina de Lisboa; Lisboa Portugal

3. Instituto de Medicina Molecular; Lisboa Portugal

4. Department of Neurology; Salford Royal Hospital; Salford UK

5. Department of Medicine; McMaster University; Hamilton Canada

6. The Cure Parkinson's Trust; London UK

7. Department of Neurology; Lancashire Teaching Hospitals NHS Foundation Trust; Preston UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference88 articles.

1. Athauda D Budnik N Chowdhury K Skene S Foltynie T The effect of exenatide on specific non-motor symptoms in Parkinson’s disease - a post-hoc analysis European Journal of Neurology Issue S2 edition Abstracts of the 4th Congress of the European Academy of Neurology, Lisbon, Portugal, June 2018 2018 309

2. Post hoc analysis of the exenatide-PD trial - factors that predict response;Athauda;European Journal of Neuroscience,2019

3. What effects might exenatide have on non-motor symptoms in Parkinson's disease: a post hoc analysis;Athauda;Journal of Parkinson’s Disease,2018

4. Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial;Athauda;Lancet,2017

5. Is exenatide a treatment for Parkinson's disease?;Athauda;Journal of Parkinson's Disease,2017

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease;European Journal of Pharmacology;2024-11

3. Unlocking longevity with GLP-1: A key to turn back the clock?;Maturitas;2024-08

4. Das Parkinson-Syndrom in der allgemeinmedizinischen Praxis;Geriatrie up2date;2024-07

5. Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models;Current Issues in Molecular Biology;2024-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3